REGENXBIO Inc.

NASDAQ:RGNX

7.41 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 24.19722.29515.62222.21328.91419.97719.13831.34526.51232.64922.218398.65530.77322.03518.88421.44598.91216.56617.64411.76814.77.8810.88440.7775.30640.031132.3912.041.3366.5620.4551.6960.1252.3750.3934.4411.141.3630.6441.1480.4831.5492.937
Cost of Revenue 12.38714.638.46315.57312.3889.4754.11212.78313.09412.95115.71723.05814.1059.8194.85110.25717.3644.6843.4093.7912.4941.9270.0292.8430.5173.8722.40813.7880.6831.3170.0910.330.0350.4980.0960.8830.2570.310.0530.1510.0121.1481.482
Gross Profit 11.817.6657.1596.6416.52610.50215.02618.56213.41819.6986.501375.59716.66812.21614.03311.18881.54811.88214.2357.97712.2065.9540.85537.9344.78936.159129.983-11.7480.6535.2450.3641.3660.091.8770.2973.5580.8831.0530.5910.9970.4710.4011.455
Gross Profit Ratio 0.4880.3440.4580.2990.5720.5260.7850.5920.5060.6030.2930.9420.5420.5540.7430.5220.8240.7170.8070.6780.830.7550.9670.930.9030.9030.982-5.7590.4890.7990.80.8050.720.790.7560.8010.7750.7730.9180.8680.9750.2590.495
Reseach & Development Expenses 54.42944.81850.66451.34658.18359.88658.51662.50563.31361.00855.62747.97847.85545.88239.72247.1843.96838.11137.03533.80735.69229.48325.20324.32918.50821.48619.5514.1712.51813.91716.61916.05912.5610.686.1834.8125.6644.0122.7912.0921.0850.850.937
General & Administrative Expenses 19.42218.85518.29119.07923.08323.69822.63421.2120.92120.83222.31822.0421.0318.42517.83817.57115.85915.55414.83314.4512.40213.40511.55811.1449.0088.3188.384.8089.4446.3556.6225.7426.26.1695.4794.2322.5673.3971.7161.1191.071.0260.634
Selling & Marketing Expenses 0000000000000000000000000000000000000000000
SG&A 19.42218.85518.29119.07923.08323.69822.63421.2120.92120.83222.31822.0421.0318.42517.83817.57115.85915.55414.83314.4512.40213.40511.55811.1449.0088.3188.384.8089.4446.3556.6225.7426.26.1695.4794.2322.5673.3971.7161.1191.071.0260.634
Other Expenses 0.037-0.0290.034-0.1180.220.0260.033-7.3820.229-0.3910.08343.8165.1310.1350.5150.0887.770.050.0678.2310.00800.0299.6820.5133.8722.4081.8250.6831.3170.0910.8570.0310.45800.990.256000000
Operating Expenses 73.88863.70268.92170.54381.48683.6181.18376.33384.46382.23178.02862.00174.01664.44258.07564.83967.59753.71551.93548.30148.10242.82636.76135.48427.51429.80927.95819.0221.96220.30123.28621.83518.75816.82911.5489.0448.2267.3494.5843.1962.1471.0020.62
Operating Income -62.078-56.037-61.762-63.903-64.96-73.108-66.157-57.771-71.045-62.533-71.527313.596-57.348-52.226-44.042-53.65113.951-41.833-37.7-40.324-35.896-36.872-35.9062.45-22.7256.35102.025-16.598-21.309-15.056-22.922-20.469-18.668-14.952-11.251-5.501-7.347-6.296-3.993-2.217-1.701-0.6010.821
Operating Income Ratio -2.566-2.513-3.954-2.877-2.247-3.66-3.457-1.843-2.68-1.915-3.2190.787-1.864-2.37-2.332-2.5020.141-2.525-2.137-3.427-2.442-4.679-40.6180.06-4.2830.1590.771-8.136-15.95-2.294-50.378-12.069-149.344-6.296-28.628-1.239-6.445-4.619-6.2-1.931-3.522-0.3880.28
Total Other Income Expenses Net 2.4813.048-1.5680.8623.0921.047-0.519-2.207-4.439-5.646-5.237-6.17-1.057-5.413-6.09313.153-5.1637.571-2.33811.4691.14735.2863.6083.4772.2318.0942.2140.6010.6030.5830.9290.4260.5140.5150.4830.3230.0150.006-0.018-0.119-0.092-0.071-0.026
Income Before Tax -59.597-52.989-63.33-63.041-61.868-72.061-66.676-59.978-75.484-68.179-76.764307.426-58.405-57.639-50.135-40.4988.788-34.262-40.038-28.855-34.749-1.586-32.2985.927-20.49414.444104.239-15.997-20.706-14.473-21.993-20.043-18.154-14.437-10.768-5.178-7.332-6.29-4.011-2.336-1.793-0.6720.795
Income Before Tax Ratio -2.463-2.377-4.054-2.838-2.14-3.607-3.484-1.913-2.847-2.088-3.4550.771-1.898-2.616-2.655-1.8880.089-2.068-2.269-2.452-2.364-0.201-36.5360.145-3.8620.3610.787-7.842-15.499-2.206-48.336-11.818-145.232-6.079-27.399-1.166-6.432-4.615-6.228-2.035-3.712-0.4340.271
Income Tax Expense 000-0.152-2.7481.123.274-0.0434.4396.86-0.04113.4036.7096.3660.0045.743-0.003-0.52.338-2.391-0.165-0.129-0.071.621-1.2923.85-0.188-1.324-0.603-0.583-0.929-0.435-0.51400-0.34500-3.9730.1010.067-0.071-0.026
Net Income -59.597-52.989-63.33-62.889-61.868-72.061-69.95-59.935-79.923-68.179-76.723294.023-58.405-57.639-50.139-46.2418.791-33.762-40.038-26.464-34.584-1.457-32.2284.306-19.20210.594104.239-15.997-20.706-14.473-21.993-19.608-18.154-14.437-10.768-5.178-7.332-6.29-4.011-2.336-1.793-0.5580.214
Net Income Ratio -2.463-2.377-4.054-2.831-2.14-3.607-3.655-1.912-3.015-2.088-3.4530.738-1.898-2.616-2.655-2.1560.089-2.038-2.269-2.249-2.353-0.185-36.4570.106-3.6190.2650.787-7.842-15.499-2.206-48.336-11.561-145.232-6.079-27.399-1.166-6.432-4.615-6.228-2.035-3.712-0.360.073
EPS -1.17-1.05-1.38-1.43-1.41-1.66-1.61-1.38-1.85-1.58-1.796.87-1.37-1.36-1.2-1.240.24-0.91-1.08-0.72-0.94-0.04-0.890.12-0.560.333.3-0.52-0.67-0.47-0.82-0.74-0.69-0.55-0.41-0.2-1.52-0.26-0.31-0.18-0.14-0.210.081
EPS Diluted -1.17-1.05-1.38-1.43-1.41-1.66-1.61-1.38-1.85-1.58-1.796.67-1.37-1.36-1.2-1.240.23-0.91-1.08-0.72-0.94-0.04-0.890.11-0.560.33.04-0.51-0.67-0.47-0.82-0.74-0.69-0.55-0.41-0.2-1.52-0.26-0.31-0.18-0.14-0.210.081
EBITDA -54.816-48.489-57.177-57.343-55.872-66.506-59.743-51.542-65.981-58.676-68.043316.202-48.868-49.072-41.504-37.62210.964-32.13-38.044-38.401-34.03-35.123-34.2923.761-21.7847.246102.859-15.875-20.603-14.353-22.368-19.763-18.508-14.896-11.203-5.462-7.319-6.2810-2.199-1.67600
EBITDA Ratio -2.265-2.332-3.686-2.682-2.245-3.436-3.453-1.841-2.545-1.83-3.0980.787-1.768-2.245-2.229-2.4960.23-2.742-1.843-4.328-2.344-8.837-42.18-0.011-4.6830.1510.77-8.431-15.873-2.276-51.202-12.069-152.176-6.272-28.506-1.305-6.417-4.608-6.2-1.916-3.470.028-0.207